Message from Chairman
Inter Pharma Public Company Limited (“the Company”) is aware of sustainable business development. By continuously giving importance to the environment, society and good corporate governance. In parallel with the company's business operations, we develop integrated health products for people and animals. The company has therefore clearly defined the concept of sustainable development by focusing on 3 components: (1) Innovation Driven Organization (2) Good Corporate Governance, Risk Management and Compliance (3) Stakeholder Long Term Value Creation. The Company believes that when the Company has good operations based on a strong foundation, and taking into account stakeholders. The Company will be able to create growth in the business and ultimately create sustainability for society as a whole. The Company is still committed to developing and delivering quality products that meet customer standards.
In 2023, the Company is aware of environmental problems and greenhouse gas emissions problems. The Company has therefore installed a solar rooftop at its factory in Ayutthaya Province to reduce greenhouse gas emissions and reduce the company's expenses, at the same time, the Company has continuously expanded its investment by investing in the Gene Therapy business with GTRI in Japan. GTRI is engaged in the research and development of Gene therapy to treat Parkinson's disease, which increases business growth and enables the Company to be a leader in the integrated health business as planned.
The Company would like to thank employees, shareholders, customers, partners, and all stakeholders that provides support and good cooperation that allows the Company's business to develop, progress, and grow sustainably. The Company will continue to adhere to and follow the principles of good corporate governance.
Clinical Professor Emeritus Udom Kachintorn, MD
Chairman
